| Affiliation: | 1. Nagoya University School of Health Sciences, Nagoya, Japan;2. Department of Biomedical Sciences, Chubu University, Kasugai, Japan;3. Molecular Carcinogenesis, Nagoya University Graduate School of Medicine, Nagoya, Japan;4. Department of Cell Signaling, Gifu Graduate School of Medicine, Gifu, Japan;5. Molecular Oncology, Institute of Aging and Adaptation, Shinshu University Graduate School of Medicine, Asashi, Japan;6. Division of Molecular Pathology, Aichi Cancer Center, Nagoya, Japan;7. Gifu International Institute of Biotechnology, Kakamigahara, Japan;1. CHU de Bordeaux, Service d''Ophtalmologie, Bordeaux, F-33000, France;2. Université de Bordeaux, F-33000 Bordeaux, France;1. Program in Neural & Behavioral Science and Robert F. Furchgott Center for Neural & Behavioral Science, USA;2. Department of Physiology and Pharmacology, Downstate Medical Center, State University of New York, Box 29, 450 Clarkson Ave, Brooklyn, NY 11203-2098, USA;3. Ottawa Health Research Institute (Neuroscience), University of Ottawa, Ontario, Canada K1H 8M5;4. CSI/IBR Center for Developmental Neuroscience and Developmental Disabilities, USA;5. Department of Chemistry (CSI), CUNY College of Staten Island, USA;1. Department of Medicine, Stony Brook, NY 11794, USA;2. The Stony Brook Cancer Center, Stony Brook, NY 11794, USA;1. HiPep Laboratories, Nakatsukasa-cho 486-46, Kamigyo-ku, Kyoto 602-8158, Japan;2. Tokyo University of Agriculture, Sakuragaoka 1-1-1, Setagayaku, Tokyo 156-0054, Japan;1. Centro de Química-Física Molecular and Institute of Nanoscience and Nanotechnology, Instituto Superior Técnico, Universidade de Lisboa, Complexo I, Av. Rovisco Pais, 1049-001 Lisboa, Portugal;2. iMed.UL – Research Institute for Medicines and Pharmaceutical Sciences, Faculdade de Farmácia, Universidade de Lisboa, Av. Prof. Gama Pinto, 1649-003 Lisboa, Portugal |
